Nano-X Imaging (NNOX) Non-Current Assets (2019 - 2026)
Nano-X Imaging (NNOX) posted quarterly Non-Current Assets of $94.4 million for Q1 2026, down 26.66% year-on-year from $128.8 million in Q1 2025, and down 0.98% on a QoQ basis from $95.4 million in Q4 2025.
Nano-X Imaging (NNOX) Non-Current Assets (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Non-Current Assets for 8 consecutive years, with $94.4 million the latest figure, recorded in Q1 2026.
- Quarterly Non-Current Assets fell 26.66% year-over-year to $94.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.4 million (down 26.66% YoY) and the FY2025 annual result came in at $95.4 million, down 27.38% from the prior year.
- Non-Current Assets retreated to $94.4 million in Q1 2026 per NNOX's latest filing, from $95.4 million in the prior quarter.
- Over the last five years, Non-Current Assets for NNOX reached as high as $269.1 billion in Q1 2022 and fell as low as $94.4 million in Q1 2026.
- A 5-year average of $42.0 billion and a median of $130.0 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 1203873.15% — and 2023, when it slumped 99.94%.
- Year by year, Non-Current Assets stood at $171.5 million in 2022, then fell by 24.18% to $130.0 million in 2023, then increased by 1.01% to $131.3 million in 2024, then fell by 27.38% to $95.4 million in 2025, then dropped by 0.98% to $94.4 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $94.4 million, $95.4 million, and $124.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn | 94.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.44 Mn |
| Dec 31, 2025 | 95.37 Mn |
| Sep 30, 2025 | 124.77 Mn |
| Jun 30, 2025 | 126.75 Mn |
| Mar 31, 2025 | 128.77 Mn |
| Dec 31, 2024 | 131.32 Mn |
| Sep 30, 2024 | 123.50 Mn |
| Jun 30, 2024 | 126.10 Mn |
| Mar 31, 2024 | 126.84 Mn |
| Dec 31, 2023 | 130.01 Mn |
| Sep 30, 2023 | 133.69 Mn |
| Jun 30, 2023 | 147.37 Mn |
| Mar 31, 2023 | 157.11 Mn |
| Dec 31, 2022 | 171.47 Mn |
| Sep 30, 2022 | 215.08 Bn |
| Jun 30, 2022 | 227.96 Bn |
| Mar 31, 2022 | 269.09 Bn |
| Dec 31, 2021 | 268.31 Mn |
| Sep 30, 2021 | 106.39 Mn |
| Jun 30, 2021 | 68.53 Mn |